SE511313C2 - Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol - Google Patents
Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerolInfo
- Publication number
- SE511313C2 SE511313C2 SE9700061A SE9700061A SE511313C2 SE 511313 C2 SE511313 C2 SE 511313C2 SE 9700061 A SE9700061 A SE 9700061A SE 9700061 A SE9700061 A SE 9700061A SE 511313 C2 SE511313 C2 SE 511313C2
- Authority
- SE
- Sweden
- Prior art keywords
- composition
- composition according
- weight
- diglycerol
- phase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9700061A SE511313C2 (sv) | 1997-01-13 | 1997-01-13 | Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol |
CA002277377A CA2277377C (en) | 1997-01-13 | 1998-01-08 | Controlled release composition |
US09/341,294 US6660278B1 (en) | 1997-01-13 | 1998-01-08 | Controlled release composition |
DE69815659T DE69815659T2 (de) | 1997-01-13 | 1998-01-08 | Zusammensetzung zur kontrollierten freisetzung |
AU55832/98A AU5583298A (en) | 1997-01-13 | 1998-01-08 | Controlled release composition |
JP53080298A JP2001508773A (ja) | 1997-01-13 | 1998-01-08 | 徐放性組成物 |
PCT/SE1998/000009 WO1998030206A1 (en) | 1997-01-13 | 1998-01-08 | Controlled release composition |
EP98900793A EP0954287B1 (en) | 1997-01-13 | 1998-01-08 | Controlled release composition |
AT98900793T ATE243024T1 (de) | 1997-01-13 | 1998-01-08 | Zusammensetzung zur kontrollierten freisetzung |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9700061A SE511313C2 (sv) | 1997-01-13 | 1997-01-13 | Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol |
Publications (3)
Publication Number | Publication Date |
---|---|
SE9700061D0 SE9700061D0 (sv) | 1997-01-13 |
SE9700061L SE9700061L (sv) | 1998-07-14 |
SE511313C2 true SE511313C2 (sv) | 1999-09-06 |
Family
ID=20405393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9700061A SE511313C2 (sv) | 1997-01-13 | 1997-01-13 | Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol |
Country Status (9)
Country | Link |
---|---|
US (1) | US6660278B1 (ja) |
EP (1) | EP0954287B1 (ja) |
JP (1) | JP2001508773A (ja) |
AT (1) | ATE243024T1 (ja) |
AU (1) | AU5583298A (ja) |
CA (1) | CA2277377C (ja) |
DE (1) | DE69815659T2 (ja) |
SE (1) | SE511313C2 (ja) |
WO (1) | WO1998030206A1 (ja) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020153508A1 (en) | 2000-06-29 | 2002-10-24 | Lynch Matthew Lawrence | Cubic liquid crystalline compositions and methods for their preparation |
AU2002335077B2 (en) * | 2001-10-19 | 2006-09-07 | Idexx Laboratories, Inc. | Injectable compositions for the controlled delivery of pharmacologically active compound |
US6946137B2 (en) * | 2001-10-19 | 2005-09-20 | Idexx Laboratories, Inc. | Methods for the controlled delivery of pharmacologically active compounds |
US7439268B2 (en) * | 2003-07-18 | 2008-10-21 | Idexx Laboratories | Compositions containing prodrugs of florfenicol and methods of use |
US20050049210A1 (en) * | 2003-08-27 | 2005-03-03 | Idexx Laboratories, Inc. | Methods for the controlled delivery of pharmacologically active compounds |
DE602005008247D1 (de) * | 2004-06-04 | 2008-08-28 | Camurus Ab | Flüssige depotformulierungen |
US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
WO2007011385A2 (en) | 2004-09-28 | 2007-01-25 | Atrium Medical Corporation | Heat cured gel and method of making |
WO2006036967A1 (en) | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Solubilizing a drug for use in a coating |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US20060127437A1 (en) * | 2004-12-13 | 2006-06-15 | Misty Anderson Kennedy | Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids |
US20070059350A1 (en) * | 2004-12-13 | 2007-03-15 | Kennedy John P | Agents for controlling biological fluids and methods of use thereof |
US8535709B2 (en) * | 2004-12-13 | 2013-09-17 | Southeastern Medical Technologies, Llc | Agents for controlling biological fluids and methods of use thereof |
US8288348B2 (en) * | 2005-07-13 | 2012-10-16 | Allergan, Inc. | Cyclosporin compositions |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
WO2007047781A2 (en) | 2005-10-15 | 2007-04-26 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
EP2083875B1 (en) | 2006-11-06 | 2013-03-27 | Atrium Medical Corporation | Coated surgical mesh |
US7550625B2 (en) * | 2007-10-19 | 2009-06-23 | Idexx Laboratories | Esters of florfenicol |
EP2393472B1 (en) | 2008-12-05 | 2019-06-05 | NanoMed Holdings Pty Ltd | Amphiphile prodrugs |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
WO2011050388A1 (en) * | 2009-10-30 | 2011-05-05 | Monash University | Liquid crystal composition and method of use |
WO2011145659A1 (ja) * | 2010-05-18 | 2011-11-24 | 富士フイルム株式会社 | カロチノイド含有組成物及びその製造方法 |
EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
WO2014016428A1 (en) | 2012-07-26 | 2014-01-30 | Camurus Ab | Opioid formulations |
CN111432805B (zh) | 2017-11-27 | 2023-02-17 | 梅克里内科尼蒂翁公司 | 3α-乙炔基-3β-羟基雄甾烷-17-酮肟的药物制剂 |
SG11202107877WA (en) | 2018-06-21 | 2021-08-30 | NanoMed Holdings Pty Ltd | Platinum-based amphiphile prodrugs |
CN116867376A (zh) * | 2021-01-29 | 2023-10-10 | Ioi油脂化学品有限责任公司 | 含有聚甘油脂肪酸酯的组合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5321393B2 (ja) * | 1974-10-19 | 1978-07-03 | ||
US5264460A (en) * | 1988-05-30 | 1993-11-23 | Deutsche Solvay-Werke Gmbh | Process for preparing nonionic surfactants |
KR0148748B1 (ko) | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
IE65045B1 (en) | 1990-04-28 | 1995-10-04 | Takeda Chemical Industries Ltd | Granulated preparations and method of producing the same |
EP0580778B1 (en) * | 1991-04-19 | 1999-08-11 | LDS Technologies, Inc. | Convertible microemulsion formulations |
SE518578C2 (sv) * | 1994-06-15 | 2002-10-29 | Gs Dev Ab | Lipidbaserad komposition |
US6013269A (en) * | 1994-10-12 | 2000-01-11 | The Procter & Gamble Company | Cosmetic make-up compositions |
SE504582C2 (sv) | 1995-07-06 | 1997-03-10 | Gs Dev Ab | Cyklosporinkomposition baserad på en L2-fas |
CZ288739B6 (cs) * | 1996-08-01 | 2001-08-15 | Galena, A. S. | Cyklosporin obsahující léčivé přípravky |
-
1997
- 1997-01-13 SE SE9700061A patent/SE511313C2/sv not_active IP Right Cessation
-
1998
- 1998-01-08 DE DE69815659T patent/DE69815659T2/de not_active Expired - Lifetime
- 1998-01-08 CA CA002277377A patent/CA2277377C/en not_active Expired - Fee Related
- 1998-01-08 AT AT98900793T patent/ATE243024T1/de not_active IP Right Cessation
- 1998-01-08 AU AU55832/98A patent/AU5583298A/en not_active Abandoned
- 1998-01-08 US US09/341,294 patent/US6660278B1/en not_active Expired - Fee Related
- 1998-01-08 JP JP53080298A patent/JP2001508773A/ja not_active Ceased
- 1998-01-08 WO PCT/SE1998/000009 patent/WO1998030206A1/en active IP Right Grant
- 1998-01-08 EP EP98900793A patent/EP0954287B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
SE9700061D0 (sv) | 1997-01-13 |
CA2277377C (en) | 2007-12-18 |
SE9700061L (sv) | 1998-07-14 |
DE69815659D1 (de) | 2003-07-24 |
DE69815659T2 (de) | 2004-04-29 |
US6660278B1 (en) | 2003-12-09 |
JP2001508773A (ja) | 2001-07-03 |
EP0954287A1 (en) | 1999-11-10 |
WO1998030206A1 (en) | 1998-07-16 |
AU5583298A (en) | 1998-08-03 |
CA2277377A1 (en) | 1998-07-16 |
EP0954287B1 (en) | 2003-06-18 |
ATE243024T1 (de) | 2003-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE511313C2 (sv) | Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol | |
CA2182577C (en) | Lipophilic carrier preparations | |
Constantinides | Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects | |
CA2232541C (en) | Fractionated vegetable oil | |
MXPA01009817A (es) | Composiciones farmaceuticas orales las cuales contienen trigliceridos de cadena larga y tensioactivos lipofilicos. | |
JPH09508413A (ja) | 水中油エマルジョン | |
KR20140070430A (ko) | 피부 외용제 조성물 | |
US10080803B2 (en) | Emulsified krill phospholipid compositions | |
JP6148416B2 (ja) | コアシェル構造体及び外用剤 | |
Norn | Polyglycerol esters | |
AU6048000A (en) | Oil-core compositions for the sustained release of hydrophobic drugs | |
EP0084341B1 (en) | Emulsion-type composition for external use | |
US6235312B1 (en) | Liquid crystalline phase drug delivery vehicle | |
EP1670436B1 (en) | Composition comprising ether lipid | |
US20040213837A1 (en) | Oil-core compositions for the sustained release of hydrophobic drugs | |
EP2429510A1 (en) | Oil-in-water emulsion of mometasone and propylene glycol | |
JP2016117681A (ja) | コアシェル構造体を含有する製剤 | |
JP2001513493A (ja) | 経鼻投与用組成物 | |
JPH01174355A (ja) | 経皮、経粘膜による物質の吸収を促進する組成物 | |
RU2127124C1 (ru) | Препараты липофильных носителей | |
WO2019087696A1 (ja) | 経口医薬組成物 | |
WO2016076786A1 (en) | Mucoadhesive emollient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |